ResearcherKansas State UniversityActive in the last 2 years
Obdulia Covarrubias‐Zambrano
Matched on ORCID iD 0000-0002-9922-7971; OpenAlex author ID A5062508951. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2022: 1 paper · 2023: 1 paper · 2024: 1 paper
Papers 3
- Protease activity-based nanobiosensors for early detection of pancreatic cancer. Co-author DOI 10.18103/mra.v12i7.5632↗
- Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer. Co-author DOI 10.3390/ijms24076336↗
- A New Hope for Liquid Biopsies: Early Detection of Pancreatic Cancer By Means of Protease Activity Detection in Serum Applying a Hierarchical Decision Structure Co-author DOI 10.1101/2022.10.18.22281240↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Anup Kasi · 3 shared papers, 2022–2024 · strength 0.54
- Paper Protease activity-based nanobiosensors for early detection of pancreatic cancer. DOI 10.18103/mra.v12i7.5632↗
- Paper Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextri… DOI 10.3390/ijms24076336↗
- Paper A New Hope for Liquid Biopsies: Early Detection of Pancreatic Cancer By Means of Protease Activity Detection in Serum A… DOI 10.1101/2022.10.18.22281240↗
- Stefan H. Bossmann · 3 shared papers, 2022–2024 · strength 0.54
- Paper Protease activity-based nanobiosensors for early detection of pancreatic cancer. DOI 10.18103/mra.v12i7.5632↗
- Paper Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextri… DOI 10.3390/ijms24076336↗
- Paper A New Hope for Liquid Biopsies: Early Detection of Pancreatic Cancer By Means of Protease Activity Detection in Serum A… DOI 10.1101/2022.10.18.22281240↗
- Sangita Bhattacharyya · 1 shared paper, 2023 · strength 0.16
- Prasad R. Dandawate · 1 shared paper, 2023 · strength 0.16
- Subhash Padhyé · 1 shared paper, 2023 · strength 0.16
- Shrikant Anant · 1 shared paper, 2023 · strength 0.16
- Michael Nathan VanSaun · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.